Trial results posted: An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)

ClinicalTrials.gov records the first posting of results for study NCT04720157 on 2026-11-04. A registry posting does not establish that a treatment is effective or safe.

Why it matters

New trial results are available for scrutiny. This report describes the posting only; it does not evaluate the findings.

What remains uncertain

• The study findings have not been independently assessed by NULLPEN.

The source record

National Library of Medicine, National Institutes of Health